Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 1,717 | 2,505 | 2,910 | 2,816 | 2,564 |
| Cost of Goods | 1,303 | 1,579 | 1,469 | 1,596 | 1,535 |
| Gross Profit | 414 | 926 | 1,441 | 1,220 | 1,029 |
| Operating Expenses | 4,925 | 3,611 | 3,286 | -1,000 | 3,838 |
| Operating Income | -4,208 | -2,106 | -1,376 | -1,635 | -2,274 |
| Other Income | 140 | 28 | 29 | 1,635 | 31 |
| Pre-tax Income | -4,068 | -2,078 | -1,347 | 0 | -2,243 |
| Net Income Continuous | -4,068 | -2,078 | -1,347 | N/A | -2,243 |
| Net Income | $-4,068 | $-2,078 | $-1,347 | $N/A | $-2,243 |
| EPS Basic Total Ops | -0.30 | -0.10 | -0.10 | -0.10 | -0.20 |
| EPS Basic Continuous Ops | -0.29 | -0.15 | -0.09 | N/A | -0.16 |
| EPS Diluted Total Ops | -0.30 | -0.10 | -0.10 | -0.10 | -0.20 |
| EPS Diluted Continuous Ops | -0.29 | -0.15 | -0.09 | N/A | -0.16 |
| EBITDA(a) | $-4,151 | $-2,013 | $-1,304 | $2,288 | $-2,274 |